Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+3.34%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$5.69B
AUM Growth
-$527M
(-8.5%)
Cap. Flow
-$754M
Cap. Flow
% of AUM
-13.25%
Top 10 Holdings %
Top 10 Hldgs %
44.35%
Holding
882
New
93
Increased
308
Reduced
393
Closed
87
Top Buys
| 1 |
Exxon Mobil
XOM
|
$36.7M |
| 2 |
Chevron
CVX
|
$33M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$25.6M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
$15.9M |
| 5 |
ConocoPhillips
COP
|
$10.8M |
Top Sells
| 1 |
Energy Select Sector SPDR Fund
XLE
|
$266M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$217M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$103M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$90.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
$84.7M |
Sector Composition
| 1 | Financials | 13.89% |
| 2 | Technology | 9.88% |
| 3 | Healthcare | 7.2% |
| 4 | Energy | 6.87% |
| 5 | Real Estate | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STI
151
DELISTED
SunTrust Banks, Inc.
STI
| $5.25M | 0.09% |
83,592
-14,319
| -15% | -$900K |
|
|
PTLA
152
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.21M | 0.09% |
192,003
+37,696
| +24% | +$1.02M |
|
153
AbbVie
ABBV
$376B
| $5.2M | 0.09% |
71,549
+4,815
| +7% | +$350K |
|
154
HF Sinclair
DINO
$9.65B
| $5.2M | 0.09% |
112,316
+64,582
| +135% | +$2.99M |
|
|
SAGE
155
DELISTED
Sage Therapeutics
SAGE
| $5.2M | 0.09% |
28,372
-4,492
| -14% | -$822K |
|
|
ONCE
156
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $5.18M | 0.09% |
50,603
+22,573
| +81% | +$2.31M |
|
|
MDCO
157
DELISTED
Medicines Co
MDCO
| $5.18M | 0.09% |
+141,979
| New | +$5.18M |
|
|
BPMC
158
DELISTED
Blueprint Medicines
BPMC
| $5.14M | 0.09% |
54,512
+18,182
| +50% | +$1.72M |
|
159
Emergent Biosolutions
EBS
$407M
| $5.14M | 0.09% |
106,398
+26,947
| +34% | +$1.3M |
|
160
Alnylam Pharmaceuticals
ALNY
$59.4B
| $5.14M | 0.09% |
70,777
+11,052
| +19% | +$802K |
|
161
Ionis Pharmaceuticals
IONS
$9.46B
| $5.13M | 0.09% |
79,864
+9,477
| +13% | +$609K |
|
162
Alkermes
ALKS
$4.77B
| $5.1M | 0.09% |
226,147
+94,911
| +72% | +$2.14M |
|
|
SGEN
163
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.01M | 0.09% |
72,383
+530
| +0.7% | +$36.7K |
|
164
Murphy Oil
MUR
$3.67B
| $4.98M | 0.09% |
202,025
+103,550
| +105% | +$2.55M |
|
165
Neurocrine Biosciences
NBIX
$13.9B
| $4.98M | 0.09% |
58,919
-5,611
| -9% | -$474K |
|
166
Ventas
VTR
$30.8B
| $4.97M | 0.09% |
72,683
-9,926
| -12% | -$678K |
|
167
Digital Realty Trust
DLR
$55.5B
| $4.95M | 0.09% |
42,038
-5,676
| -12% | -$669K |
|
|
ICPT
168
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.95M | 0.09% |
62,176
+13,041
| +27% | +$1.04M |
|
169
United Therapeutics
UTHR
$17.2B
| $4.93M | 0.09% |
63,196
+17,735
| +39% | +$1.38M |
|
|
PDCE
170
DELISTED
PDC Energy, Inc.
PDCE
| $4.93M | 0.09% |
136,649
+65,048
| +91% | +$2.35M |
|
171
Regenxbio
RGNX
$498M
| $4.91M | 0.09% |
95,640
+37,742
| +65% | +$1.94M |
|
|
GBT
172
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.82M | 0.08% |
91,588
-7,561
| -8% | -$398K |
|
173
PBF Energy
PBF
$3.27B
| $4.81M | 0.08% |
153,541
+73,871
| +93% | +$2.31M |
|
174
iShares MSCI Mexico ETF
EWW
$1.82B
| $4.78M | 0.08% |
110,156
+34,226
| +45% | +$1.48M |
|
175
Wolfspeed
WOLF
$194M
| $4.77M | 0.08% |
84,939
+5,448
| +7% | +$306K |
|